IBD Ventures, LLC - Orange Comet Series L
Built from the SEC filing index the day the filing landed. The figures below are the issuer's own from Form D; AltStreet's analysis, sponsor link and data flags follow when the entity is enriched.
Raised
$2M
Investors
28
Min Invest
$10,000
Is this your company or fund? Claim this page free, or verify it and carry the Verified Issuer mark.
What this filing shows
·Every sentence is a value as filed on SEC Form D
IBD Ventures, LLC - Orange Comet Series L is a Delaware limited liability company that first filed a Form D on October 17, 2022 and most recently amended it on March 14, 2023, describing itself as a private equity fund. The offering claims Rule 506(b), Section 3(c), Section 3(c)(1) and covers equity and pooled investment fund interests. IBD Ventures, LLC - Orange Comet Series L reported $1,817,038 sold from 28 investors in an offering of indefinite size as of the Form D filed March 14, 2023. The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000. The Form D names I-Bankers Direct, LLC (CRD 167533), associated with None as the recipient of sales compensation soliciting in AZ, CA, CO, CT, FL, GA, KY, MD, NJ, NV, NY, TX. The issuer's address of record is 2500 N. Military Trail, Suite 160, Boca Raton, FL 33431.
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
lapsed
Investor
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
IBD Management LLC
Executive Officer, Director, Promoter · BOCA RATON, FL
Managing Member of the Issuer.
Robert Spitler
Executive Officer · BOCA RATON, FL
Managing Member of the Managing Member.
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
I-Bankers Direct, LLCCRD 167533 on BrokerCheck
Associated broker-dealer: None · BOCA RATON, FL · Soliciting in AZ, CA, CO, CT, FL, GA, KY, MD, NJ, NV, NY, TX and outside the United States
Questions About IBD Ventures, LLC - Orange Comet Series L
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is IBD Ventures, LLC - Orange Comet Series L?
IBD Ventures, LLC - Orange Comet Series L is a Delaware limited liability company that filed a Form D with the SEC on March 14, 2023 as a private equity fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(1) for an offering of equity and pooled investment fund interests.
Is IBD Ventures, LLC - Orange Comet Series L legit?
AltStreet does not rate legitimacy; it reports the public record. IBD Ventures, LLC - Orange Comet Series L filed a Form D with the SEC on March 14, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(1). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $1,817,038 sold to 28 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is IBD Ventures, LLC - Orange Comet Series L registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that IBD Ventures, LLC - Orange Comet Series L claimed Rule 506(b), Section 3(c), Section 3(c)(1) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has IBD Ventures, LLC - Orange Comet Series L raised?
IBD Ventures, LLC - Orange Comet Series L reported $1,817,038 sold from 28 investors in an offering of indefinite size as of the Form D filed March 14, 2023.
Who can invest in IBD Ventures, LLC - Orange Comet Series L?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(1), it may have no more than 100 beneficial owners. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $10,000.
What is the minimum investment in IBD Ventures, LLC - Orange Comet Series L?
The Form D lists $10,000 as the minimum investment accepted from any outside investor as of March 14, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling IBD Ventures, LLC - Orange Comet Series L and how are they paid?
The Form D names I-Bankers Direct, LLC (CRD 167533), associated with None as the recipient of sales compensation soliciting in AZ, CA, CO, CT, FL, GA, KY, MD, NJ, NV, NY, TX.
Who is behind IBD Ventures, LLC - Orange Comet Series L?
The Form D lists 2 related persons: IBD Management LLC, executive officer, director, promoter (Managing Member of the Issuer); Robert Spitler, executive officer (Managing Member of the Managing Member). Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is IBD Ventures, LLC - Orange Comet Series L located?
The issuer's address on its SEC filings is 2500 N. Military Trail, Suite 160, Boca Raton, FL 33431. Its phone number of record is 561-220-8858. It is organized under the laws of Delaware.
How long is the IBD Ventures, LLC - Orange Comet Series L offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is IBD Ventures, LLC - Orange Comet Series L?
The issuer declined to disclose its revenue range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Verified Issuer, $480 a year: AltStreet checks the identity of your company and the authority of the person claiming it against your filings, confirms your contact details on a stated date and again at each renewal, and marks the page so people researching you find a current, attributed profile beside the public filing record. It is not a review of any offering.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.